For patients experiencing rapid Hb decline, comorbid conditions (such as cardiac, pulmonary, or cerebrovascular disease), or anemia-related symptoms (including tachycardia, chest pain, dizziness, or dyspnea), RBC transfusion is recommended. This evidence concerns the gene GSTM1 and cerebrovascular disorder.